Sandostatin LAR (Octreotide long-acting)
Brand: Sandostatin LAR
Active Ingredient(s): Octreotide long-acting
Strength: 20 mg – 30 mg – 10 mg
Pack Size: 1 unit – 1 unit – 1 unit Injectable
Store in the refrigerator.
DIN: 02239324 – 02239325 – 02239323
Manufacturer: Novartis Pharma Canada Inc. (Canada)
Alternatives: Sandostatin – Octreotide Acetate – Teva Octreotide – Sandostatin multi dose
*A valid prescription is required for Rx items.
Description
Sandostatin LAR (Octreotide long-acting) is a somatostatin analogue agent (drug that stop your body from making too many hormones). It is typically used to treat acromegaly (a condition caused by increased levels of growth hormone (GH). GH helps your body used energy and build bones, muscles, and tissues). It is also used to reduce flushing episodes (redness of the skin together with a sensation of warmth or burning) and watery diarrhea caused by certain types of tumors (vasoactive intestinal polypeptide secreting tumors, metastatic carcinoid tumors). It may also have other uses.
Additional information
Sandostatin LAR (Octreotide long-acting)'s dosage depends on the condition being treated. Your doctor or pharmacist may have suggested a schedule that is more appropriate for you. Your doctor or nurse will administer Sandostatin LAR (Octreotide long-acting) to you in a hospital or clinical setting. WARNING: Use with caution in patient with cardiovascular (heart) problems. Use with caution in patients with hepatic (liver) problems. Use with caution in patient with renal (kidney) problems. In addition to its desired action, Sandostatin LAR (Octreotide long-acting) may cause some side effects, notably: It may cause high blood pressure, sinus bradycardia (a regular but unusually slow heart beat). It may cause alopecia (hair loss), skin rash, hyperglycemia (an excess of sugar in the bloodstream). It may cause nausea, vomiting, diarrhea, abdominal pain, peripheral edema (swelling of the lower legs or hands). Contraindications: Hypersensitivity to octreotide or any component of the formulation. Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. If you're planning a pregnancy or become pregnant, or breastfeeding contact your family doctor. A treatment with Sandostatin LAR (Octreotide long-acting) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Sandostatin LAR (Octreotide long-acting)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews